Quote this publication Share Print

BERINERT

-
Opinions on drugs - Posted on Jun 28 2012

Reason for request

Inclusion on the list of medicines approved for hospital use.

-


Clinical Benefit

Substantial

The actual benefit of this medicinal product is substantial.


Clinical Added Value

moderate

BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children.


Contact Us

Évaluation des médicaments

See also